| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.9M | +49.5% | +190.9% |
| Cost of Revenue | $2.7M | +130.3% | +130.5% |
| Gross Profit | $6.2M | +29.3% | +229.1% |
| R&D Expense | $56.4M | -2.9% | +4.3% |
| SG&A Expense | $30.4M | +16.6% | +45.8% |
| Operating Income | -$80.6M | -1.6% | -10.4% |
| Pre-tax Income | -$437.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $687.6M | +294.0% | +1216.1% |
| Accounts Receivable | $7.7M | — | — |
| Current Assets | $712.5M | — | — |
| Total Assets | $1.07B | — | — |
| Current Liabilities | $68.3M | — | — |
| Long-term Debt | $179.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$183.4M | — | — |
| Capital Expenditures | $25.7M | — | — |
| Investing Cash Flow | -$24.4M | — | — |
| Financing Cash Flow | $598.4M | — | — |
| Free Cash Flow | -$209.0M | — | — |
| -444.9% |
| -483.6% |
| Income Tax | $253K | +10.5% | +32.5% |
| Net Income | -$437.2M | -443.7% | -482.5% |
| EPS (Basic) | -$9.83 | -386.6% | -443.1% |
| EPS (Diluted) | -$9.83 | -386.6% | -443.1% |
| — |
| Total Liabilities | $279.4M | — | — |
| Stockholders' Equity | $789.9M | +169.4% | +302.9% |